Astellas offers shareable resources focused on educating and assisting nuclear lab providers as they care for their patients. We aim to support your team’s efforts to communicate and collaborate before, during, and after the cardiac testing process, leveraging specialized expertise, all to help facilitate the best possible patient experience and support lab efficiency.
Explore customizable handouts and informative websites on the diagnosis of CAD, cardiac testing preparation, and more, to help support your clinical decisions, educational outreach, and operational processes in your nuclear lab.
Designed for your patients and staff, this card serves as a reminder that patients undergoing a nuclear stress test need to avoid caffeine and other products containing methylxanthines because they will interfere with test results.
This provides an overview of single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI), including whom it can be used for, how it is used, and what the results may indicate. It also discusses how to prepare patients for stress MPI.
Understanding SPECT MPI and Preparing Your Patient is intended for nuclear cardiologists, technologists, nurses, and other healthcare providers to present to and share with their colleagues.
A resource with information about the Multimodality AUC and the CMS federal mandate, plus a downloadable AUC tool to help guide imaging decisions.
This useful app allows providers in the nuclear lab to review the appropriateness of 7 different cardiac testing modalities (based on the AUC) for the detection and risk assessment of SIHD.
The Multimodality AUC App is not intended to diagnose, treat, or prevent any disease or condition. It is also not a qualified Clinical Decision Support Mechanism (CDSM). Thus, the Multimodality AUC App must not be used to try and comply with the Centers for Medicare & Medicaid Services (CMS) Appropriate Use Criteria (AUC) program requirements. The Multimodality AUC App is for informational purposes only.
This booklet provides information intended for providers who are the first to see at-risk patients and details guideline-based pathways for evaluating CAD. Share this booklet with those healthcare providers who consider whether cardiac testing or treatment may be appropriate for their patient.
Share the Noninvasive Modalities booklet with referring and ordering providers. It provides an overview of the evaluation and risk assessment of CAD, as well as the various noninvasive testing modalities for diagnosis. For the applicable modalities, this educational booklet considers the risks vs benefits, diagnostic accuracy, functional vs anatomic measures, local expertise and availability, cost effectiveness, and appropriate use.
Help facilitate a shared understanding of cardiovascular care through utilizing this informative booklet on the clinical value of SPECT in evaluating CAD. Designed for referring and ordering providers, this resource offers information on cardiac testing and helps keep your healthcare team informed.
Astellas Pharma Support Solutionssm offers access and reimbursement support to help patients overcome challenges to accessing Astellas products.
For technical support, please contact us.